article thumbnail

BMS: Delayed new drug to avoid paying billions?

World of DTC Marketing

billion on Thursday for allegedly delaying its Breyanzi cancer drug to avoid payments to shareholders of the former Celgene Corp, which the drugmaker bought in 2019. Food and Drug Administration approval for the non-Hodgkin lymphoma drug by a Dec. The post BMS: Delayed new drug to avoid paying billions?

article thumbnail

Cardiovascular Medical Device Sales With Marc Toth

Evolve Your Success

The foods are put on the trays, then go up to the person who has a diabetic diet. It’s the first drug-eluting heart stent in the world. I’ve done the startup from scratch and built sales teams to try to sell a new device. Content without a sales pitch, they love it. This guy feeds in the hospital.

Medical 52